biologics

Auto Added by WPeMatico

affordable cancer treatment biologics Business News enzene biosciences Health HER2 breast cancer Hetero Healthcare HTDS News oncology pertuzumab biosimilar Perzea PNN News Press Release UNI News

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences

September 25, 2025
Health

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advanced cancer treatment accessibility. Innovation Meets […]

K J Somaiya Institute of Management organises International MSME Conference 2025 in collaboration with INDAM

Supreme Group Successfully Executes First NMG Railway Movement for Mahindra and Volkswagen Skoda

Transforming Cancer Care: EarlySure Diagnostics Brings Precision Oncology to India

World Mental Health Day 2025: Expert Advice on Access to Care in Times of Crisis

B.A.G. Convergence Limited Commences Trading with Impressive Market Response on NSE Emerge

biologics

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences